Skip to main content

Advertisement

Volume 3 Supplement 1

ESICM LIVES 2015

Intensive care admission in patients with hellp syndrome in a tertiary referral hospital

Article metrics

  • 274 Accesses

Introduction

Every year, 500.000 mothers die from pregnancy-related complications, and 99% of these deaths occur in low- and middle-income countries [1]. These maternal deaths occur from complications associated with pre-eclampsia or eclampsia; hemolysis elevated liver enzymes, and low platelet (HELLP) syndrome, or other hypertensive disorder of pregnancy [2].

Objectives

To identify risk factors affecting maternal outcome among women with Hemolysis, Elevated Liver Enzymes, and Low Platelets (HELLP) syndrome who required transfer for critical care.

Methods

All 77 women with HELLP syndrome who sought care for delivery and postpartum assessment at the emergency department, and who were treated in our intensive care unit between January 2007 and July 2012 were identified, retrospectively. Findings were analyzed according to surviving and non-surviving patients.

Results

Maternal mortality rate was 14% and perinatal death occurred in 24 of 81 fetuses and newborn (30%). The most common cause of maternal complications was disseminated intravascular coagulation in 22 patients (29%), acute renal failure in 19 patients (25%), and postpartum hemorrhage in 16 patients (21%). Compared with surviving women, non-surviving women had higher mean values for international normalized ratio (p < 0.0001), levels of serum aspartate aminotransferase (p < 0.0001), serum alanine aminotransferase (p < 0.0001), lactate dehydrogenase (p < 0.0001), and bilirubin (p = 0.040) and lower platelet count (p = 0.005).

Conclusions

The patients with HELLP syndrome should be treated in intensive care unit, especially after cesarean delivery. Disseminated intravascular coagulation is major risk factor affecting maternal outcome.

References

  1. 1.

    World Health Organization: The World Health Report 2005: make every mother and child count. 2005, Geneva, World Health Organization

  2. 2.

    Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol. 2009, 33: 130-7. 10.1053/j.semperi.2009.02.010.

Download references

Author information

Correspondence to E Gedik.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gedik, E., Yücel, N., Sahin, T. et al. Intensive care admission in patients with hellp syndrome in a tertiary referral hospital. ICMx 3, A909 (2015) doi:10.1186/2197-425X-3-S1-A909

Download citation

Keywords

  • Cesarean Delivery
  • Maternal Death
  • Disseminate Intravascular Coagulation
  • Eclampsia
  • Elevated Liver Enzyme